share_log

Barclays Downgrades Helmerich & Payne to Equal-Weight, Lowers Price Target to $40

Barclays Downgrades Helmerich & Payne to Equal-Weight, Lowers Price Target to $40

巴克莱将Helmerich和Payne的评级下调至同等权重,将目标股价下调至40美元
Benzinga ·  01/10 06:48

Barclays analyst David Anderson downgrades Helmerich & Payne (NYSE:HP) from Overweight to Equal-Weight and lowers the price target from $44 to $40.

巴克莱分析师戴维·安德森将Helmerich & Payne(纽约证券交易所代码:HP)的评级从增持下调至同等,并将目标股价从44美元下调至40美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发